Corporate News 27-Jan-23
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
Gland Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at the Company's API Facility at JNPC, Visakhapatnam from 23 January 2023 to 27 January 2023 and has been completed with Zero observations.
Previous News
Stock alert: Indus Towers, Gland Pharma, Advanced Enzyme, DMart, Sapphire Foods
( Market Commentary - Stock Alert 20-Jun-24 08:50 )
Gland Pharma receives USFDA approval for Cetrorelix Acetate for Injection
( Corporate News - 29-Apr-24 10:49 )
Gland Pharma allots 6,200 equity shares under ESOS
( Corporate News - 14-Feb-24 15:10 )
Gland Pharma gains as Q4 PAT soars to Rs 192 cr
( Hot Pursuit - 23-May-24 11:42 )
Gland Pharma to hold AGM
( Corporate News - 23-May-24 09:38 )
Gland Pharma consolidated net profit declines 15.05% in the December 2022 quarter
( Results - Announcements 23-Jan-23 17:31 )
Board of Gland Pharma recommends final dividend
( Corporate News - 23-May-24 09:38 )
Gland Pharma allots 2,400 equity shares under ESOS
( Corporate News - 26-Mar-24 09:55 )
Gland Pharma consolidated net profit declines 72.48% in the March 2023 quarter
( Results - Announcements 19-May-23 07:25 )
Gland Pharma tumbles after Q4 PAT declines over 72% YoY
( Hot Pursuit - 19-May-23 09:37 )
Gland Pharma announces board meeting date
( Corporate News - 18-Oct-23 12:10 )
Other Stories
Gujarat Natural Resources to convene board meeting
05-Oct-24 17:43
Narmada Macplast Drip Irrigation Sys. to convene board meeting
05-Oct-24 17:43
Grill Splendour Services to conduct board meeting
05-Oct-24 17:43
Consolidated Construction Consortium to hold board meeting
05-Oct-24 17:43
Visagar Polytex to announce Quarterly Result
05-Oct-24 17:42
GNA Axles to convene board meeting
05-Oct-24 17:42
Fidel Softech to conduct board meeting
05-Oct-24 17:42
Rita Finance & Leasing announces board meeting date
05-Oct-24 17:42
Pelatro to conduct EGM
05-Oct-24 17:36
Thinkink Picturez to hold AGM
05-Oct-24 17:35
Back
Top
